Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03708003
Brief Title: Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

First Submitted : October 12, 2018
First Submitted that Met QC Criteria : October 12, 2018
First Posted : October 16, 2018

Last Update Submitted that Met QC Criteria : August 28, 2020
Last Update Posted : August 31, 2020